This message was sent to ##Email##
|
| April 11, 2018 |
| |  | | |
|
|
|
| |
Reuters
The proportion of boys and young men in the U.S. receiving the human papillomavirus vaccine has more than tripled since 2011, new research shows.
Among 9 to 26-year-old males, 27 percent had received at least one dose of the vaccine in 2016, compared to 8 percent in 2011.
READ MORE
| Announcing the 2018 'Rookie of the Year' Scholarship Winner
|
    |
ASCT
ASCT is pleased to announce the winner of the new “Rookie of the Year” Scholarship! The scholarship aims to support an individual in attending the ASCT Annual Conference. The winner will receive $900 to use towards expenses for the upcoming 2018 meeting in Salt Lake City!
The scholarship was founded by active ASCT member and cytotechnologist, Victoria Lingua. Victoria has been a cytotechnologist and tremendous advocate for the field for many years. She is passionate about cytotechnology, education, and participation in the ASCT. Attending meetings provides access to invaluable resources, networking opportunities, and a sense of community. Through this scholarship, Victoria and the ASCT hope to inspire those with budding careers to become more involved in the society and to continue to provide these crucial opportunities for members.
Applicants must be active ASCT members in their first 5 years of practice. They must submit a completed application form along with an essay, which will be published in the Voice, on what membership in the ASCT means to them, how they plan to become more involved, why attending the upcoming meeting is important to them, and why the scholarship is important at this point in their careers.
This year’s applicants were impressive in their desire to further the field of cytotechnology and become involved in cytology organizations at the local and national levels. We are excited to announce that this year’s award winner is Kelsey Snyder, MS, CT(ASCP)CM, from the Roswell Park Comprehensive Cancer Center. We congratulate Kelsey and look forward to meeting her at this year’s conference!
| Date |
Event |
Location |
More information |
June 20, 2018 |
The Bethesda System for Cervical Cytology — Update and Beyond
|
Your PC |
Patricia G. Tiscornia-Wasserman, MD
Professor of Pathology and Cell Biology
Director of Cytopathology
Columbia University Medical Center
Melville, New York
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
MedicalXpress
Typically cancers are classified by where they originate in the body — think breast cancer, stomach cancer and so on. But a collaboration called the Pan-Cancer Initiative, launched in 2012 at a meeting in Santa Cruz, California, sought to study cancers from a new angle — a molecular one.
READ MORE
Medical News Today
New research has revealed the chameleonic abilities of lung cancer cells: By adopting the traits of cells from other major organs, lung cancer cells may escape chemotherapy. The findings open up paths for more targeted therapies.
READ MORE
News-Medical.net
Researchers of the Universitat Politècnica de València and the Universidad de Granada, together with doctors from the Hospital Clínic Universitari de València are working on the development of a new system to help diagnose prostate cancer. The work being developed is part of the SICAP project.
READ MORE
The New York Times
Researchers have made new discoveries about the in-between spaces in the human body, and some say it’s time to rewrite the anatomy books. A study published in Scientific Reports this week described a fluid-filled, 3-D latticework of collagen and elastin connective tissue that can be found all over the body, in or near our lungs, skin, digestive tracts and arteries.
READ MORE
Medscape
Sarcopenia, or low levels of skeletal muscle mass, is a highly prevalent though largely unrecognized risk factor for overall mortality in women with stage II and III nonmetastastic breast cancer, an observational study suggests.
READ MORE
Science Daily
Non-small-cell lung cancer, the most common type of lung cancer, is the leading cause of cancer death in the U.S. A new study suggests that about 1 in 4 cases, those driven by the KRAS oncogene, could be successfully treated with a combination of drugs that are already available clinically.
READ MORE
News-Medical.net
Researchers from Columbia University and New York-Presbyterian have created patient-specific bladder cancer organoids that imitate many of the features of real tumors.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
